Impacto de COVID-19 en la enfermedad cardiovascular

Autores/as

  • Cristhian Felipe Ramírez-Ramos Universidad Pontificia Bolivariana - Clínica CardioVID
  • Diego Mauricio Vanegas Universidad Pontificia Bolivariana - Clínica CardioVID
  • Diego A Ramírez Méndez Universidad Surcolombiana
  • Gustavo Adolfo Castilla Agudelo Universidad Pontificia Bolivariana
  • Mateo Aranzazu Uribe Universidad Pontificia Bolivariana
  • Ricardo Fernández Ruiz Universidad Pontificia Bolivariana - Clínica CardioVID
  • Carlos Esteban Uribe Londoño Universidad Pontificia Bolivariana - Clínica CardioVID
  • Luz Adriana Ocampo Aristizabal Universidad Pontificia Bolivariana - Clínica CardioVID
  • Alvaro Mauricio Quintero Ossa Universidad Pontificia Bolivariana - Clínica CardioVID
  • Catalina Gallego Universidad Pontificia Bolivariana - Clínica CardioVID
  • Clara Inés Saldarriaga Giraldo Universidad Pontificia Bolivariana - Clínica CardioVID - Universidad de Antioquia

DOI:

https://doi.org/10.21615/cesmedicina.34.COVID-19.18

Palabras clave:

Coronavirus, Terapia cardiovascular, Complicaciones

Resumen

La enfermedad por coronavirus-2019 (COVID-19) es una enfermedad infecciosa cuya sintomatología inicial, en la mayoría de las ocasiones, se manifiesta con compromiso del tracto respiratorio. El virus que causa dicha enfermedad se denomina síndrome respiratorio agudo severo por coronavirus 2 (SARS-CoV2). Si bien la manifestación grave más frecuente de la infección parece ser la neumonía, se han documentado diversas implicaciones cardiovasculares. Las personas que cursan con dicha infección y que tienen una enfermedad cardiovascular preexistente tienen un riesgo mayor de cuadros graves y mortalidad. Existen asociaciones directas o indirectas de la infección con injuria miocárdica, arritmias, enfermedad tromboembólica venosa y miocarditis. Los tratamientos en investigación pueden tener efectos adversos en el sistema eléctrico del corazón; además, algunos medicamentos de uso crónico (como los inhibidores del sistema renina angiotensina aldosterona) se les ha otorgado un polémico papel en la virulencia del microorganismo. La alta demanda en atención en salud que requieren los pacientes infectados por SARS-CoV 2 puede  comprometer la asistencia de pacientes cardiovasculares sin dicha infección y dejar en riesgo de exposición al personal sanitario. Se presenta una revisión sobre los aspectos más llamativos donde estas dos condiciones interaccionan.

Descargas

Los datos de descargas todavía no están disponibles.

Referencias bibliográficas

Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 30;382 (18):1708–20.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Lond Engl. 2020 15;395 (10223):497–506.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 hospitalized patients with 2019 novel Coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323 (11):1061–9.

Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi Zhonghua Liuxingbingxue Zazhi. 2020 Feb 10;41 (2):145–51.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet Lond Engl. 2020 15;395 (10223):507–13.

Liu K, Fang Y-Y, Deng Y, Liu W, Wang M-F, Ma J-P, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020 May 5;133 (9):1025–31.

Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63 (3):364–74.

Zhang J-J, Dong X, Cao Y-Y, Yuan Y-D, Yang Y-B, Yan Y-Q, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75 (7):1730–41.

Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi Zhonghua Liuxingbingxue Zazhi. 2020 Feb 17;41 (2):145–51.

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020 May;94:91–5.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8 (5):475–81.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet Lond Engl. 2020 28;395 (10229):1054–62.

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46 (5):846–8.

Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020 Jun;63 (3):390–1.

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Jul 1;5 (7):802–10.

Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020 May 12;

Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 27; doi: 10.1001/jamacardio.2020.3557. ahead of print.

Kwok CS, Gale CP, Kinnaird T, Curzen N, Ludman P, Kontopantelis E, et al. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction. Heart Br Card Soc. 2020 Aug 31; doi: 10.1136/heartjnl-2020-317650. Online ahead of print.

Garcia S, Stanberry L, Schmidt C, Sharkey S, Megaly M, Albaghdadi MS, et al. Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2020 Aug 7; doi: 10.1002/ccd.29154. Online ahead of print.

Solomon MD, McNulty EJ, Rana JS, Leong TK, Lee C, Sung S-H, et al. The Covid-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med. 2020 13;383 (7):691–3.

De Filippo O, D’Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A, et al. Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy. N Engl J Med. 2020 02;383 (1):88–9.

Shah K, Tang D, Ibrahim F, Ghosh B, Bhatti S, Akhabue E, et al. Surge in delayed myocardial infarction presentations: an inadvertent consequence of social distancing during the COVID-19 Pandemic. JACC Case Rep. 2020 Aug;2 (10):1642–7.

Choudry FA, Hamshere SM, Rathod KS, Akhtar MM, Archbold RA, Guttmann OP, et al. High thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2020 08;76 (10):1168–76.

Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, et al. ST-segment elevation in patients with Covid-19 - A Case Series. N Engl J Med. 2020 18;382 (25):2478–80.

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1;5 (7):811–8.

Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020 28;323 (16):1612–4.

Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020 23;382 (17):1653–9.

Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In Vitro Antiviral Activity and Projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis Off Publ Infect Dis Soc Am. 2020 28;71 (15):732–9.

Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 Pandemic. J Am Coll Cardiol. 2020 12;75 (18):2352–71.

Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012 May 17;366 (20):1881–90.

Chu CM, Cheng VCC, Hung IFN, Wong MML, Chan KH, Chan KS, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004 Mar;59 (3):252–6.

Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19 - Preliminary report. N Engl J Med. 2020 May 22; doi: 10.1056/NEJMoa2007764. Online ahead of print.

Li F, Cai J, Dong N. First cases of COVID-19 in heart transplantation from China. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2020;39 (5):496–7.

Danziger-Isakov LA, Husain S, Mooney ML, Hannan MM, ISHLT Infectious Diseases Council. The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2009 Dec;28 (12):1341–7.

Descargas

Publicado

12-06-2020

Cómo citar

Ramírez-Ramos, C. F. ., Vanegas, D. M., Ramírez Méndez, D. A., Castilla Agudelo, G. A. ., Aranzazu Uribe, M., Fernández Ruiz, R., … Saldarriaga Giraldo, C. I. (2020). Impacto de COVID-19 en la enfermedad cardiovascular. CES Medicina, 34, 128–136. https://doi.org/10.21615/cesmedicina.34.COVID-19.18

Número

Sección

Revisión de tema
Estadísticas de artículo
Vistas de resúmenes
Vistas de PDF
Descargas de PDF
Vistas de HTML
Otras vistas

Algunos artículos similares: